Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 3
2016 1
2018 2
2019 2
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: . Clear all
Page 1
Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models.
Burley TA, Da Pieve C, Martins CD, Ciobota DM, Allott L, Oyen WJG, Harrington KJ, Smith G, Kramer-Marek G. Burley TA, et al. Among authors: allott l. J Nucl Med. 2019 Mar;60(3):353-361. doi: 10.2967/jnumed.118.216069. Epub 2018 Sep 13. J Nucl Med. 2019. PMID: 30213849 Free PMC article.
HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging.
Martins CD, Da Pieve C, Burley TA, Smith R, Ciobota DM, Allott L, Harrington KJ, Oyen WJG, Smith G, Kramer-Marek G. Martins CD, et al. Among authors: allott l. Clin Cancer Res. 2018 Apr 15;24(8):1853-1865. doi: 10.1158/1078-0432.CCR-17-2754. Epub 2018 Feb 6. Clin Cancer Res. 2018. PMID: 29437790 Free PMC article.
Synthesis of a benzoxazinthione derivative of tanaproget and pharmacological evaluation for PET imaging of PR expression.
Allott L, Miranda C, Hayes A, Raynaud F, Cawthorne C, Smith G. Allott L, et al. EJNMMI Radiopharm Chem. 2019 Jan 10;4(1):1. doi: 10.1186/s41181-018-0054-z. EJNMMI Radiopharm Chem. 2019. PMID: 31659497 Free PMC article.
PET Imaging of Steroid Hormone Receptor Expression.
Allott L, Smith G, Aboagye EO, Carroll L. Allott L, et al. Mol Imaging. 2015;14(10):534-50. doi: 10.2310/7290.2015.00026. Mol Imaging. 2015. PMID: 26505328 Free article. Review.
[18F]FET-βAG-TOCA: The Design, Evaluation and Clinical Translation of a Fluorinated Octreotide.
Allott L, Dubash S, Aboagye EO. Allott L, et al. Cancers (Basel). 2020 Apr 2;12(4):865. doi: 10.3390/cancers12040865. Cancers (Basel). 2020. PMID: 32252406 Free PMC article. Review.
Development of PDT/PET Theranostics: Synthesis and Biological Evaluation of an (18)F-Radiolabeled Water-Soluble Porphyrin.
Entract GM, Bryden F, Domarkas J, Savoie H, Allott L, Archibald SJ, Cawthorne C, Boyle RW. Entract GM, et al. Among authors: allott l. Mol Pharm. 2015 Dec 7;12(12):4414-23. doi: 10.1021/acs.molpharmaceut.5b00606. Epub 2015 Nov 23. Mol Pharm. 2015. PMID: 26559906
Efficient [(18)F]AlF Radiolabeling of ZHER3:8698 Affibody Molecule for Imaging of HER3 Positive Tumors.
Da Pieve C, Allott L, Martins CD, Vardon A, Ciobota DM, Kramer-Marek G, Smith G. Da Pieve C, et al. Among authors: allott l. Bioconjug Chem. 2016 Aug 17;27(8):1839-49. doi: 10.1021/acs.bioconjchem.6b00259. Epub 2016 Jul 19. Bioconjug Chem. 2016. PMID: 27357023 Free article.
Carbon-11 radiolabelling of organosulfur compounds: (11) C synthesis of the progesterone receptor agonist tanaproget.
Haywood T, Kealey S, Sánchez-Cabezas S, Hall JJ, Allott L, Smith G, Plisson C, Miller PW. Haywood T, et al. Among authors: allott l. Chemistry. 2015 Jun 15;21(25):9034-8. doi: 10.1002/chem.201501089. Epub 2015 May 12. Chemistry. 2015. PMID: 25965348
Chemistry Considerations for the Clinical Translation of Oncology PET Radiopharmaceuticals.
Allott L, Aboagye EO. Allott L, et al. Mol Pharm. 2020 Jul 6;17(7):2245-2259. doi: 10.1021/acs.molpharmaceut.0c00328. Epub 2020 Jun 5. Mol Pharm. 2020. PMID: 32433888
Development of a fluorine-18 radiolabelled fluorescent chalcone: evaluated for detecting glycogen.
Allott L, Brickute D, Chen C, Braga M, Barnes C, Wang N, Aboagye EO. Allott L, et al. EJNMMI Radiopharm Chem. 2020 Jun 23;5(1):17. doi: 10.1186/s41181-020-00098-6. EJNMMI Radiopharm Chem. 2020. PMID: 32578021 Free PMC article.
11 results
Jump to page